Correlation Between Ziff Davis and Biodexa Pharmaceticals
Can any of the company-specific risk be diversified away by investing in both Ziff Davis and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ziff Davis and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ziff Davis and Biodexa Pharmaceticals, you can compare the effects of market volatilities on Ziff Davis and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ziff Davis with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ziff Davis and Biodexa Pharmaceticals.
Diversification Opportunities for Ziff Davis and Biodexa Pharmaceticals
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ziff and Biodexa is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Ziff Davis and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and Ziff Davis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ziff Davis are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of Ziff Davis i.e., Ziff Davis and Biodexa Pharmaceticals go up and down completely randomly.
Pair Corralation between Ziff Davis and Biodexa Pharmaceticals
Allowing for the 90-day total investment horizon Ziff Davis is expected to under-perform the Biodexa Pharmaceticals. But the stock apears to be less risky and, when comparing its historical volatility, Ziff Davis is 1.91 times less risky than Biodexa Pharmaceticals. The stock trades about -0.07 of its potential returns per unit of risk. The Biodexa Pharmaceticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 450.00 in Biodexa Pharmaceticals on November 4, 2024 and sell it today you would lose (9.00) from holding Biodexa Pharmaceticals or give up 2.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ziff Davis vs. Biodexa Pharmaceticals
Performance |
| Timeline |
| Ziff Davis |
| Biodexa Pharmaceticals |
Ziff Davis and Biodexa Pharmaceticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ziff Davis and Biodexa Pharmaceticals
The main advantage of trading using opposite Ziff Davis and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ziff Davis position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.| Ziff Davis vs. Interpublic Group of | Ziff Davis vs. Criteo Sa | Ziff Davis vs. WPP PLC ADR | Ziff Davis vs. Integral Ad Science |
| Biodexa Pharmaceticals vs. SNDL Inc | Biodexa Pharmaceticals vs. Sun Country Airlines | Biodexa Pharmaceticals vs. CanSino Biologics | Biodexa Pharmaceticals vs. flyExclusive, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |